Moderna鈥檚 mRNA RSV vaccine wins expanded FDA approval for younger adults
The label expansion for Moderna鈥檚 jab arrives at a juncture in America鈥檚 changing vaccine regulatory landscape.

The label expansion for Moderna鈥檚 jab arrives at a juncture in America鈥檚 changing vaccine regulatory landscape.
The platform enables evaluation of drug targets based on therapeutic, biological and market potential.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Pharma鈥檚 AI prospects get nudged into the future with EU鈥檚 AI act聽
Next-generation targeting for evolving HCP engagement
Are regulators keeping pace with AI adoption in clinical trials?
Recursion axes drug programmes to streamline pipeline 聽